COOLTIME-MD
MRP: 780
Packaging: 10x10
Pack Type: tablet
Composition:
Granisetron 1mg (M.D)
Indication:
Treatment of post-operative nausea and vomiting in adults. Nausea and vomiting associated with initial and repeat courses of emetogenic cancer therapy, including high-dose cisplatin. Nausea and vomiting associated with radiation.
Description:
Granisetron 1 mg (M.D.) is a selective 5-HT3 receptor antagonist used to prevent and treat nausea and vomiting caused by chemotherapy, radiotherapy, and surgery. By blocking serotonin receptors in the central nervous system and gastrointestinal tract, Granisetron effectively controls acute and delayed emesis, improving patient comfort during cancer treatment or post-operative recovery.
Tags:
- Effective control of nausea and vomiting in cancer therapy
- Helps improve patient quality of life during treatment
- Rapid onset of action
- Well tolerated with minimal side effects
- Useful in both acute and delayed nausea prevention
Usage Information
Dosage
Adults: Typically, 1 mg orally 30 minutes before chemotherapy or as prescribed Dosage may be repeated based on treatment protocol Follow your healthcare provider’s instructions strictly Not recommended for self-medication
Side Effects
Headache Constipation Dizziness or fatigue Rare: Allergic reactions, QT prolongation Report severe or persistent symptoms immediately
Contraindications
Hypersensitivity to Granisetron or related compounds Patients with congenital long QT syndrome Use caution in patients with heart conditions Not recommended during pregnancy or breastfeeding without doctor’s advice
Availability
Granisetron 1 mg Anti-nausea medication Chemotherapy nausea relief 5-HT3 receptor antagonist Post-surgery vomiting prevention Granisetron tablet Antiemetic for cancer patients Radiation therapy nausea control Granisetron dosage 1 mg Nausea and vomiting treatment